Polymeric Nanoparticles Containing Taxanes Enhance Chemoradiotherapeutic Efficacy in Non-small Cell Lung Cancer

Autor: Seong-Yun Jeong, Heon Joo Park, Eun Kyung Choi, Si Yeol Song, Hye Kyung Chung, Hye-Won Kang, Sa-Won Lee, Joohee Jung, Sungjin Park, Min Hyo Seo
Rok vydání: 2012
Předmět:
Male
inorganic chemicals
Radiation-Sensitizing Agents
Cancer Research
Pathology
medicine.medical_specialty
Lung Neoplasms
Paclitaxel
Polymers
medicine.medical_treatment
Mice
Nude

Docetaxel
Nanoconjugates
Flow cytometry
Ionizing radiation
Mice
Random Allocation
Carcinoma
Non-Small-Cell Lung

Cell Line
Tumor

medicine
Animals
Humans
heterocyclic compounds
Radiology
Nuclear Medicine and imaging

Lung cancer
Clonogenic assay
A549 cell
Mice
Inbred BALB C

Radiation
medicine.diagnostic_test
business.industry
Drug Synergism
Chemoradiotherapy
medicine.disease
Antineoplastic Agents
Phytogenic

Xenograft Model Antitumor Assays
Endocytosis
Radiation therapy
enzymes and coenzymes (carbohydrates)
Oncology
Cell culture
Microscopy
Electron
Scanning

Cancer research
Feasibility Studies
Taxoids
business
medicine.drug
Zdroj: International Journal of Radiation Oncology*Biology*Physics. 84:e77-e83
ISSN: 0360-3016
DOI: 10.1016/j.ijrobp.2012.02.030
Popis: Purpose To reduce the side effects and improve the efficacy of chemoradiation therapy, taxanes were incorporated into polymeric nanoparticles (PNP), and their synergic effect on radiation therapy in non-small cell lung cancer was evaluated. Methods and Materials The properties of PNP-taxanes were characterized by transmission electron microscopy and dynamic light scattering. The chemoradiotherapeutic efficacy of PNP-taxanes was determined by clonogenic assay, cellular morphology, and flow cytometry in A549 cells. In mice bearing A549-derived tumors, the tumor growth delay was examined after the treatment of PNP-taxanes and/or ionizing radiation (IR). Results The PNP-taxanes were found to be approximately 45 nm in average diameter and to have high solubility in water. They showed the properties of active internalization into cells and preserved the anticancer effect of free taxanes. The survival fraction of A549 cells by clonogenic assay was significantly reduced in the group receiving combined treatment of PNP-taxanes and IR. In addition, in vivo radiotherapeutic efficacy was markedly enhanced by the intravenous injection of PNP-taxanes into the xenograft mice. Conclusions We have demonstrated the feasibility of PNP-taxanes to enhance the efficacy of chemoradiation therapy. These results suggest PNP-taxanes can hold an invaluable and promising position in treating human cancers as a novel and effective chemoradiation therapy agent.
Databáze: OpenAIRE